News
-
-
-
-
-
PRESS RELEASE
BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)
BioNxt announces successful completion of GMP manufacturing for sublingual Cladribine oral thin film, advancing to clinical-stage execution. Company aims to treat MS and neurodegenerative diseases -
-
-
-
-
PRESS RELEASE
Financial Conduct Authority:
The Financial Conduct Authority announces admission of various securities to the Official List. Issuers include International Finance Corporation, Credit Agricole Corporate and Investment Bank, The State of Qatar, HSBC Bank PLC, Santander UK PLC, and Heathrow Funding Limited